Further reduction in nonvertebral fracture rate is observed following 3 years of denosumab treatment: results with up to 7 years in the freedom extension

Authors
Publication date
1 January 2014
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Open Repository and Bibliography - Liège

    redirect
    oaioai:orbi.ulg.ac.be:2268/165049
    Last time updated on 25/04/2014